Stutsky explains why shifting therapy perceptions had more pharmacist touchpoints and longer time on therapy among patients with ATTR-CM.
|Articles|March 22, 2012
Dr. Michael Sherman Discusses Companion Diagnostics
In this video, Dr. Michael Sherman, Senior Vice President and Chief Medical Officer at Harvard Pilgrim Heath Care, discusses the evolution of companion diagnostic testing, and some of the concerns with cost and coding.
Advertisement
In this video, Dr. Michael Sherman, Senior Vice President and Chief Medical Officer at
This video was taken at the 4th Annual Forum for Payers on Personalized Medicine conference in Washington, DC, on March 12, 2012.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
2
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
3
Multi-Hit TP53 Linked to Shorter Survival in Chronic-Phase MPN Cohorts
4
5 Things to Know About Eye Injury Prevention Month
5